{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-017984","form_type":"8-K","ticker":"EVFM","cik":"0001618835","company_name":"Evofem Biosciences, Inc.","filed_at":"2023-05-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.688120+00:00","generated_at":"2026-06-14T22:24:23.713817+00:00","sec_items":["5.03","7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Evofem Biosciences announces 1-for-125 reverse stock split effective May 18","bullets":["Reverse split ratio 1-for-125; reduces outstanding shares from ~249M to ~1.99M as of May 17, 2023.","New CUSIP 30048L302; trades under EVFMD for 20 business days, then reverts to EVFM.","No fractional shares issued; cash in lieu at closing price on May 17, 2023.","Proportional adjustments to exercise prices and shares of stock options, warrants, convertible notes.","Approved by stockholders at special meeting March 15, 2023; Board set exact ratio."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-017984","json":"https://secwatch.observer/filing/0001493152-23-017984.json","markdown":"https://secwatch.observer/filing/0001493152-23-017984.md","text":"https://secwatch.observer/filing/0001493152-23-017984.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1618835/000149315223017984/0001493152-23-017984-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1618835/000149315223017984/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T22:24:23.713817+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4a81b1520e14c4a0f72c4c87fdaaa710123532b7","claim":"Evofem Biosciences, Inc.: Amended certificate of incorporation to effect a 1-for-125 reverse stock split, effective May 18, 2023 (effective 2023-05-18).","evidence_excerpt":"On May 17, 2023, the Company filed with the Secretary of State of the State of Delaware a Certificate of Correction (the “Certificate of Correction”) to change the effective time of the Reverse Stock Split from May 3, 2023 to May 18, 2023. As a result, the Reverse Stock Split will become effective upon the open of trading on the OTC Venture Market on May 18, 2023 (the “Effective Time”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1618835/000149315223017984/0001493152-23-017984-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-05-18"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}